Diabetic Retinopathy and Antivascular Endothelial Growth Factor Agents

Abstract

17. clinicaltrials.gov. Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. NCT01627249. https://clinicaltrials.gov/ct2/show /NCT01627249. Accessed March 16, 2017. 18. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. 19. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology. 1991;98(5) (suppl):823-833. 20. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988; 75(4):800-802. 21. Mitchell P, Bandello F, Schmidt-Erfurth U, et al; RESTORE Study Group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625. 22. clinicaltrials.gov. Anti-VEGF Treatment for Prevention of PDR/DME. NCT02634333. https://clinicaltrials.gov/ct2/show/NCT02634333. Accessed March 17, 2017.